GlassScriptPhysician profile
Anna M Lozano
NPI 1396706636
$659.97
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2020: $123 · 2021: $213 · 2024: $59.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $40.05 · Food and Beverage: $19.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $40.05 |
| Food and Beverage | $19.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $163.43 | 2019-2021 | |
| Hologic Sales and Service, LLC | $142.16 | 2019-2021 | |
| Avion Pharmaceuticals | $63.36 | 2019-2020 | |
| Therapeuticsmd, INC. | $41.79 | 2019-2020 | |
| Millicent US INC | $40.05 | 2024 | |
| Duchesnay USA Incorporated | $33.27 | 2019 | |
| Amag Pharmaceuticals, INC. | $29.05 | 2019 | |
| Aspira Women'S Health INC | $26.61 | 2020 | |
| Vertical Pharmaceuticals, LLC | $24.79 | 2020 | |
| Pfizer INC. | $19.24 | 2024 | |
| Acessa Health INC. | $19.13 | 2019 | |
| Dysis Medical, INC. | $16.53 | 2021 | |
| Exeltis, USA INC. | $16.51 | 2019 | |
| Lupin INC. | $12.53 | 2019 | |
| Allergan, INC. | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Lozano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.